Influence of exposure time and pressure amplitude on blood-brain-barrier opening using transcranial ultrasound exposures

Rajiv Chopra, Natalia Vykhodtseva, Kullervo Hynynen

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Pulsed ultrasound exposures of brain tissue in the presence of microbubble contrast agents have been shown to achieve transient focal disruption of the blood-brain barrier without significant damage to surrounding brain tissue. The effects of overall exposure duration on the extent of blood-brain barrier disruption was studied in these experiments to determine operating conditions for increasing the amount of therapeutic agents delivered to the brain. Exposures at 1.08 MHz ranging from 0.2 to 0.8 MPa in amplitude were delivered transcranially to the brains of rabbits and rats for durations ranging from 30 to 1200 s. The amount of signal enhancement on contrast-enhanced T1-weighted MR images were used to quantify the extent of blood-brain barrier disruption, and histological evaluation of the exposed regions was performed to evaluate the impact on brain tissue. A subset of four rats underwent weekly exposures for 3 weeks to evaluate the feasibility of repeat sonications to the brain. The results suggest that exposures less than 180 s in duration are associated with a low probability of irreversible damage to brain tissue at pressure amplitudes of 0.38 MPa. Although exposures greater than 300 s were associated with an increase in the proportion of irreversible damage, this may be acceptable for chemotherapy delivery, where the therapeutic goal is tissue destruction. Repeat exposures to the brain were feasible but resulted in evidence of focal brain damage in 50% of animals.

Original languageEnglish (US)
Pages (from-to)391-398
Number of pages8
JournalACS Chemical Neuroscience
Volume1
Issue number5
DOIs
StatePublished - May 19 2010

Fingerprint

Blood-Brain Barrier
Brain
Ultrasonics
Pressure
Tissue
Rats
Microbubbles
Sonication
Chemotherapy
Contrast Media
Animals
Rabbits
Drug Therapy
Therapeutics

Keywords

  • Blood-brain barrier
  • Focused ultrasound
  • Microbubbles
  • MRI
  • Ultrasound

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Physiology
  • Cognitive Neuroscience

Cite this

Influence of exposure time and pressure amplitude on blood-brain-barrier opening using transcranial ultrasound exposures. / Chopra, Rajiv; Vykhodtseva, Natalia; Hynynen, Kullervo.

In: ACS Chemical Neuroscience, Vol. 1, No. 5, 19.05.2010, p. 391-398.

Research output: Contribution to journalArticle

@article{b9856a8de3094faba686c0536f2829d3,
title = "Influence of exposure time and pressure amplitude on blood-brain-barrier opening using transcranial ultrasound exposures",
abstract = "Pulsed ultrasound exposures of brain tissue in the presence of microbubble contrast agents have been shown to achieve transient focal disruption of the blood-brain barrier without significant damage to surrounding brain tissue. The effects of overall exposure duration on the extent of blood-brain barrier disruption was studied in these experiments to determine operating conditions for increasing the amount of therapeutic agents delivered to the brain. Exposures at 1.08 MHz ranging from 0.2 to 0.8 MPa in amplitude were delivered transcranially to the brains of rabbits and rats for durations ranging from 30 to 1200 s. The amount of signal enhancement on contrast-enhanced T1-weighted MR images were used to quantify the extent of blood-brain barrier disruption, and histological evaluation of the exposed regions was performed to evaluate the impact on brain tissue. A subset of four rats underwent weekly exposures for 3 weeks to evaluate the feasibility of repeat sonications to the brain. The results suggest that exposures less than 180 s in duration are associated with a low probability of irreversible damage to brain tissue at pressure amplitudes of 0.38 MPa. Although exposures greater than 300 s were associated with an increase in the proportion of irreversible damage, this may be acceptable for chemotherapy delivery, where the therapeutic goal is tissue destruction. Repeat exposures to the brain were feasible but resulted in evidence of focal brain damage in 50{\%} of animals.",
keywords = "Blood-brain barrier, Focused ultrasound, Microbubbles, MRI, Ultrasound",
author = "Rajiv Chopra and Natalia Vykhodtseva and Kullervo Hynynen",
year = "2010",
month = "5",
day = "19",
doi = "10.1021/cn9000445",
language = "English (US)",
volume = "1",
pages = "391--398",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - Influence of exposure time and pressure amplitude on blood-brain-barrier opening using transcranial ultrasound exposures

AU - Chopra, Rajiv

AU - Vykhodtseva, Natalia

AU - Hynynen, Kullervo

PY - 2010/5/19

Y1 - 2010/5/19

N2 - Pulsed ultrasound exposures of brain tissue in the presence of microbubble contrast agents have been shown to achieve transient focal disruption of the blood-brain barrier without significant damage to surrounding brain tissue. The effects of overall exposure duration on the extent of blood-brain barrier disruption was studied in these experiments to determine operating conditions for increasing the amount of therapeutic agents delivered to the brain. Exposures at 1.08 MHz ranging from 0.2 to 0.8 MPa in amplitude were delivered transcranially to the brains of rabbits and rats for durations ranging from 30 to 1200 s. The amount of signal enhancement on contrast-enhanced T1-weighted MR images were used to quantify the extent of blood-brain barrier disruption, and histological evaluation of the exposed regions was performed to evaluate the impact on brain tissue. A subset of four rats underwent weekly exposures for 3 weeks to evaluate the feasibility of repeat sonications to the brain. The results suggest that exposures less than 180 s in duration are associated with a low probability of irreversible damage to brain tissue at pressure amplitudes of 0.38 MPa. Although exposures greater than 300 s were associated with an increase in the proportion of irreversible damage, this may be acceptable for chemotherapy delivery, where the therapeutic goal is tissue destruction. Repeat exposures to the brain were feasible but resulted in evidence of focal brain damage in 50% of animals.

AB - Pulsed ultrasound exposures of brain tissue in the presence of microbubble contrast agents have been shown to achieve transient focal disruption of the blood-brain barrier without significant damage to surrounding brain tissue. The effects of overall exposure duration on the extent of blood-brain barrier disruption was studied in these experiments to determine operating conditions for increasing the amount of therapeutic agents delivered to the brain. Exposures at 1.08 MHz ranging from 0.2 to 0.8 MPa in amplitude were delivered transcranially to the brains of rabbits and rats for durations ranging from 30 to 1200 s. The amount of signal enhancement on contrast-enhanced T1-weighted MR images were used to quantify the extent of blood-brain barrier disruption, and histological evaluation of the exposed regions was performed to evaluate the impact on brain tissue. A subset of four rats underwent weekly exposures for 3 weeks to evaluate the feasibility of repeat sonications to the brain. The results suggest that exposures less than 180 s in duration are associated with a low probability of irreversible damage to brain tissue at pressure amplitudes of 0.38 MPa. Although exposures greater than 300 s were associated with an increase in the proportion of irreversible damage, this may be acceptable for chemotherapy delivery, where the therapeutic goal is tissue destruction. Repeat exposures to the brain were feasible but resulted in evidence of focal brain damage in 50% of animals.

KW - Blood-brain barrier

KW - Focused ultrasound

KW - Microbubbles

KW - MRI

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=77953303635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953303635&partnerID=8YFLogxK

U2 - 10.1021/cn9000445

DO - 10.1021/cn9000445

M3 - Article

C2 - 20563295

AN - SCOPUS:77953303635

VL - 1

SP - 391

EP - 398

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 5

ER -